ダウンロード数: 168

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
12_410.pdf317.82 kBAdobe PDF見る/開く
タイトル: 泌尿器科領域に於けるセファロリジンの臨床的応用
その他のタイトル: Clinical use of cephaloridine for urological infections
著者: 重松, 俊  KAKEN_name
古野, 干城  KAKEN_name
三原, 謙  KAKEN_name
大熊, 謙彰  KAKEN_name
新井, 亨  KAKEN_name
著者名の別形: SHIGEMATSU, Shun
FURUNO, Tateki
MIHARA, Ken
OHKUMA, Yoshiaki
ARAI, Tohru
キーワード: Adult
Aged
Cephaloridine/therapeutic use
Cephalosporins/therapeutic use
Child
Female
Humans
Male
Middle Aged
Urinary Tract Infections/drug therapy
発行日: Apr-1966
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 12
号: 4
開始ページ: 410
終了ページ: 414
抄録: The report deals with a use of new medicine, Cephaloridine , CER, in the field of urology. The results obtained on 18 cases of various urological diseases are summarized as follows. 1) After single injection of CER, 0.25g or 0.125g, its blood level reached to the peak in 2 hours at the both dosage, and the effective blood level continued for the following 4 hours, although the blood level itself decreased rapidly. 2) After single injection of CER, 0.25 g, th e cumurative urinary excretion rate was 66.1% in 6 horus. 3) In 1 8 patiens with various urinary tract infections who were treated with CER, excellent, marked and no effects were obtained in 8, 6 and 4 cases respectively, with the effectiveness being 77.7%. 4) The most r e markable effect was observed in acute cases, although some effects were expectable even in chronic cases. 5) The drug was most effecti v e against Staphylococci infections. The effectiveness against E. coli was recorded as 84.6% which was also distinguishable. 6) No significant side effect was recognized. 7) In conclusion, it is recommende d to inject CER 1.0g a day, devided several times, to expect more excellent results.
URI: http://hdl.handle.net/2433/112934
PubMed ID: 6006492
出現コレクション:Vol.12 No.4

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。